Martin Verhoef and William Rich

Premium

Martin Verhoef, senior vice president for sales, marketing, and operations, will become president of Ciphergen’s new Biosystems division, as well as executive vice president, and will report to William Rich, president and CEO, the company said last week. Verhoef, who has been with Ciphergen since April 2000, will lead the company’s research products group — which sells the company’s ProteinChip systems, arrays, and services — and the bioprocess products groups.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.